QUIVER BIOSCIENCE INC.
US UEI L9HHRYCBMBZ1 · SME
14public awards
$28.2Mtotal public funding
2026-05-05latest award
State aid awards (14)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-05-05 | $1.7M | Grant | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DIS | Department of Health and Human Services |
| 2026-04-30 | $3.0M | Grant | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DIS | Department of Health and Human Services |
| 2026-04-28 | $2.0M | Grant | DRUG USE AND ADDICTION RESEARCH PROGRAMS | Department of Health and Human Services |
| 2025-12-17 | $3.0M | Grant | MENTAL HEALTH RESEARCH GRANTS | Department of Health and Human Services |
| 2025-12-17 | $2.5M | Grant | MENTAL HEALTH RESEARCH GRANTS | Department of Health and Human Services |
| 2025-05-20 | $862k | Grant | Safe-OPTION: Optical Physiology To Interrogate Oligonucleotide Neuroto | Department of Health and Human Services |
| 2023-09-19 | $3.0M | Grant | BRITE-Eye: An integrated discovery engine for CNS therapeutic targets | Department of Health and Human Services |
| 2022-09-15 | $4.0M | Grant | Ultra-High-Throughput Plate Reader for Drug Discovery Using All-Optica | Department of Health and Human Services |
| 2022-08-01 | $1.6M | Grant | A phenotypic screen for compounds that differentially affect excitator | Department of Health and Human Services |
| 2022-07-19 | $2.5M | Grant | Functional drug fingerprinting with all-optical electrophysiology | Department of Health and Human Services |
| 2021-06-01 | $2.0M | Grant | Development of anti-sense oligonucleotides as a therapeutic for cancer | Department of Health and Human Services |
| 2020-09-07 | $301k | Grant | Development of anti-sense oligonucleotides as a therapeutic for cancer | Department of Health and Human Services |
| 2020-09-01 | $1.6M | Grant | A phenotypic screen for osteoarthritic pain therapeutics using all-opt | Department of Health and Human Services |
| 2019-09-20 | $231k | Grant | A phenotypic screen for osteoarthritic pain therapeutics using all-opt | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →